Peptide and Oligonucleotide CDMO Market Size, Share and Analysis: 2034
Peptide and oligonucleotide CDMOs (Contract Development and Manufacturing Organizations) are specialized partners that assist pharmaceutical and biopharmaceutical companies in developing and producing peptide- and oligonucleotide-based therapies. These organizations provide a range of services, including process development, synthesis, scale-up, analytical testing, and large-scale...
0 التعليقات 0 المشاركات 2كيلو بايت مشاهدة 0 معاينة
flexartsocial.com https://www.flexartsocial.com